Hara Capital’s Pfizer PFE Stock Holding History

Hara Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.1K	Buy	2,248 +3	+0.1%	+$78	0.03%	186
2026 Q1	$63K	Buy	2,245 +2	+0.1%	+$53	0.03%	172
2025 Q4	$55.8K	Buy	2,243 +3	+0.1%	+$76	0.03%	177
2025 Q3	$57.1K	Buy	2,240 +3	+0.1%	+$74	0.03%	169
2025 Q2	$54.2K	Buy	2,237 +3	+0.1%	+$70	0.03%	193
2025 Q1	$56.6K	Sell	2,234 -127	-5%	-$3.32K	0.04%	175
2024 Q4	$62.6K	Sell	2,361 -593	-20%	-$16.1K	0.04%	168
2024 Q3	$85.5K	Buy	+2,954	New	+$86.2K	0.05%	164

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hara Capital's PFE Position: Q2 2026 in Review

Hara Capital increased its Pfizer (PFE) stake by 0.13% in Q2 2026, buying an estimated $78 and bringing the position to 2,248 shares worth $54.1K. The position accounts for 0.03% of the portfolio, ranked #186.

Hara Capital first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $85.5K in Q3 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Hara Capital held 2,248 shares of Pfizer worth $54.1K as of Q2 2026.
Hara Capital bought 3 Pfizer shares in Q2 2026, an estimated $78.
Pfizer made up 0.03% of Hara Capital's portfolio in Q2 2026, its #186 holding.
Hara Capital first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
Hara Capital's Pfizer position peaked at $85.5K in Q3 2024.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.